Colorectal Cancer News

News

Aarkstore.com Colorectal Cancer – Executive Market Summary 2011 | PRLog
www.prlog.org | Feb 3, 2012
Aarkstore.com Colorectal Cancer – Executive Market Summary 2011. Dear customer Aarkstore announce a new report "Colorectal Cancer – Executive Market Summary 2011 " through its vast collection of market research report - PR11789343

Chemotherapy for colorectal cancer – Authors' reply : The Lancet Oncology
www.thelancet.com | Jan 22, 2012
Chemotherapy for colorectal cancer – Authors' reply. By - Michel Ducreux, David Malka, Jean-Pierre Pignon

Bayer HealthCares Colorectal Cancer Drug
www.biospace.com | Jan 18, 2012
WAYNE, N.J., Jan. 17, 2012 /PRNewswire/ -- Bayer HealthCare today announced latest data on its investigational compound regorafenib from the Phase III

Cancer Care Partners to Host Clinical Program Titled “Colorectal Cancer: New Frontiers” by
www.prweb.com | Oct 27, 2011
On Thursday, November 10, 2011 at 7:00 p.m. EST, Cancer Care Partners welcomes surgical oncologist, Col. Alexander Stojadinovic MD, FACS to the Michiana area for an exclusive program that will explore new frontiers in clinical decision support for colorectal cancer.

AEterna Zentaris Is A Greatly Undervalued, Must-Buy Biotech - Seeking Alpha
seekingalpha.com | Oct 11, 2011
< strong > By Jeremy Richards: < /strong > < p > Since my last article AEterna Zentaris ( < a href='http://seekingalpha.com/symbol/aezs' title='AEterna Zentaris, Inc.' > AEZS < /a > ) article on April 21, 2011 < span > ( < /span > < a

Specialty Pharmaceutical Industry - 2011 Yearbook | SYS-CON MEDIA
www.sys-con.com | Aug 30, 2011
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

GP Pharm Expands its Pharmaceutical Line Against Advanced Colorectal Cancer with Oxaliplatin and
www.pharmaceutical-technology.com | Aug 30, 2011
Home Products & Services Contract Manufacturing GP Pharm Press Release Company Details White Papers Press Releases Regional Offices Contact Company GP Pharm Expands its Pharmaceutical Line Against Advanced Colorectal Cancer with Oxaliplatin and Irinotecan 300mg and 500mg Email Article Print 30

Medical News: Overscreening for Colon Cancer Cited - in Gastroenterology, Colon Cancer from MedPage
www.medpagetoday.com | May 9, 2011
For many older patients, screening for colorectal cancer is performed too often or is more likely to harm than help, researchers said.

Genetic Technology Alert. Diagnostic Detection Method for Colorectal Cancer; RNA Interference
www.frost.com | Dec 10, 2010
This issue profiles a diagnostic detection method for colorectal cancer, RNA interference targeting beta tubulin, and DGKK gene associated with hypospadias. Strategic partnership details and some important patents have also been included.

amednews: Colorectal cancer screening guidelines not consistently followed by many physicians ::
www.ama-assn.org | Nov 3, 2010
Nineteen-percent adhere to screening guidelines all the time, while 40% never follow the recommendations, often overscreening patients, a new study shows.